AVO.L
Advanced Oncotherapy PLC
Price:  
1.93 
GBP
Volume:  
3,069,660.00
United Kingdom | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVO.L WACC - Weighted Average Cost of Capital

The WACC of Advanced Oncotherapy PLC (AVO.L) is 5.2%.

The Cost of Equity of Advanced Oncotherapy PLC (AVO.L) is 7.15%.
The Cost of Debt of Advanced Oncotherapy PLC (AVO.L) is 5.00%.

Range Selected
Cost of equity 4.80% - 9.50% 7.15%
Tax rate 2.10% - 4.10% 3.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 5.6% 5.2%
WACC

AVO.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta -0.36 0.22
Additional risk adjustments 3.0% 3.5%
Cost of equity 4.80% 9.50%
Tax rate 2.10% 4.10%
Debt/Equity ratio 5.13 5.13
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 5.6%
Selected WACC 5.2%